Skip to content
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search

  • Home
  • About Us
    • Cardiawave
    • Mission and values
    • The Team
    • Careers
  • Aortic Stenosis
    • Unmet Medical Need
    • Current Treatment
  • Health Professionals
    • Our device: Valvosoft® 
    • Scientific Publications
    • Congresses
  • News
    • News
    • Press releases
  • Contact

Corporate News

  • Home
  • Blog
  • Corporate News
Corporate News

2023 is shaping up to be an exceptional year for Cardiawave !

Jan 9, 2023
READ MORE
Corporate News

WE HAVE A NEW WEBSITE!

Dec 2, 2021
READ MORE
Corporate News

WE HAVE MOVED!

Nov 10, 2021
READ MORE
Corporate News

DIRK PAUWELS, CLINICAL DIRECTOR

Sep 21, 2021
READ MORE
Corporate News

BEST VIDEO AWARD FROM MEDTECH INNOVATOR

Sep 14, 2021
READ MORE
Corporate News

MEDTECH INNOVATOR BEST VIDEO AWARD

Sep 7, 2021
READ MORE
Corporate News

NATHAN KABASELA KABASELE – TECHNICIAN STOCK OPERATOR

Aug 17, 2021
READ MORE
Corporate News

AFAQ SHAFEEQ – TEST & VALIDATION ENGINEER

Aug 3, 2021
READ MORE
Corporate News

LOIC RAZAFILAHY – BIOMEDICAL ENGINEER

Jul 1, 2021
READ MORE
420x300-events3
Corporate News

MEDTECH FORUM 2021

Apr 22, 2021
READ MORE

Posts pagination

Page 1 Page 2 NextNext page

Categories

  • About Us
  • Aortic Stenosis
  • Careers
  • Clinical Studies
  • Corporate News
  • Events
  • Other news
  • Press Release
  • Scientific Publications

l Latest news

  • Cardiawave announced positive 12-months results at EuroPCR 2025 !
  • Cardiawave annonce les résultats positifs à 12 mois de ses études “Valvosoft® FIM Study” et « Valvosoft® Pivotal Study » à l’EuroPCR!

l Our social networks

  • LinkedIn
  • Twitter

l Contact Us

3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
+ 33 (0) 1 55 26 82 16
contact@cardiawave.com

Copyright © Cardiawave l April 28th 2025
  • Legal Mentions